miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development?
Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK.|Sheffield Teaching Hospitals NHS Trust, Sheffield, S10 2JF, UK.
Alexander Mk
AM
Rothman
Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
David J
DJ
Rowlands
Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK.
Allan
A
Lawrie
D006801:Humans; D006976:Hypertension, Pulmonary; D035683:MicroRNAs
D035683:MicroRNAs
Smurf1; miR140-5p; miRNA; pulmonary arterial hypertension; remodeling; ubiquitination